Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
BJs Wholesale Club
BJ
$12.4B
| $11.9M | ﹤0.01% |
144,652
+78,470
| +119% | +$6.64M |
|
|
NARI
1352
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $11.9M | ﹤0.01% |
288,079
+25,365
| +10% | +$1.22M |
|
1353
CALL
Enphase Energy
ENPH
$5.24B
| $11.9M | ﹤0.01% |
105,000
-434,700
| -81% | -$48.6M |
|
1354
Alkermes
ALKS
$8.11B
| $11.9M | ﹤0.01% |
423,931
+220,893
| +109% | +$5.89M |
|
1355
Fortune Brands Innovations
FBIN
$6.01B
| $11.9M | ﹤0.01% |
132,531
-135,084
| -50% | -$10.4M |
|
1356
Flowserve
FLS
$10B
| $11.9M | ﹤0.01% |
229,379
+34,645
| +18% | +$1.67M |
|
1357
Alcoa
AA
$12.5B
| $11.8M | ﹤0.01% |
306,812
+81,666
| +36% | +$2.78M |
|
1358
Progyny
PGNY
$2.37B
| $11.8M | ﹤0.01% |
706,157
+594,140
| +530% | +$14.3M |
|
1359
Zions Bancorporation
ZION
$10.3B
| $11.8M | ﹤0.01% |
249,630
-343,150
| -58% | -$16.2M |
|
1360
CALL
Okta
OKTA
$24.9B
| $11.8M | ﹤0.01% |
158,500
-288,700
| -65% | -$25.2M |
|
1361
Elastic
ESTC
$7.27B
| $11.8M | ﹤0.01% |
153,155
+55,084
| +56% | +$5.43M |
|
1362
Box
BOX
$4.41B
| $11.7M | ﹤0.01% |
358,894
+211,985
| +144% | +$6.19M |
|
|
RNAM
1363
DELISTED
Avidity Biosciences
RNAM
| $11.7M | ﹤0.01% |
255,699
+163,905
| +179% | +$7.11M |
|
1364
Petrobras Class A
PBR.A
$106B
| $11.7M | ﹤0.01% |
890,000
+120,000
| +16% | +$1.63M |
|
1365
Novanta
NOVT
$5.82B
| $11.7M | ﹤0.01% |
65,564
+44,756
| +215% | +$7.78M |
|
1366
CALL
Ralph Lauren
RL
$23.6B
| $11.7M | ﹤0.01% |
60,500
-204,800
| -77% | -$35.4M |
|
1367
CALL
Rivian
RIVN
$22.3B
| $11.7M | ﹤0.01% |
1,045,000
-6,778,100
| -87% | -$97.4M |
|
1368
MGIC Investment
MTG
$6.21B
| $11.7M | ﹤0.01% |
457,706
+196,252
| +75% | +$4.73M |
|
1369
Scotiabank
BNS
$108B
| $11.7M | ﹤0.01% |
214,957
+46,421
| +28% | +$2.25M |
|
1370
CALL
Walmart Inc
WMT
$892B
| $11.7M | ﹤0.01% |
145,000
-251,100
| -63% | -$18.4M |
|
1371
Glaukos
GKOS
$10.1B
| $11.7M | ﹤0.01% |
89,699
+71,556
| +394% | +$8.9M |
|
1372
CALL
Analog Devices
ADI
$184B
| $11.7M | ﹤0.01% |
50,700
-36,800
| -42% | -$8.29M |
|
1373
ProShares S&P 500 High Income ETF
ISPY
$1.26B
| $11.7M | ﹤0.01% |
260,000
| – | – |
|
1374
CALL
Lumen
LUMN
$6.09B
| $11.6M | ﹤0.01% |
+1,639,200
| New | +$7M |
|
1375
PUT
Procter & Gamble
PG
$342B
| $11.6M | ﹤0.01% |
+67,100
| New | +$11.4M |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.